Increased expression levels of CD68 in patients with T2D also were confirmed by immunohistochemistry (Fig. 3C) and immunofluorescence (Fig. S3C), with a higher number of inflammatory cells being detected in patients with T2D. The gene discussed is CD68; the disease is type 2 diabetes mellitus.